Foot Complications and Mortality: Results from Translating Research Into Action for Diabetes (TRIAD).

Foot Complications and Mortality: Results from Translating Research Into Action for Diabetes (TRIAD).
复制标题

DOI:
10.7547/14-115
复制
发表时间:
2016-01
影响因子:
0.7
通讯作者:
Wrobel JS
Wrobel JS
中科院分区:
医学4区
文献类型:
--
作者:
McEwen LN;Ylitalo KR;Munson M;Herman WH;Wrobel JS

文献摘要

参考文献

被引文献

相似文献

Our objective was to study the impact of foot complications on 10 year mortality independent of other demographic and biological risk factors in a racially and socioeconomically diverse managed care population with access to high-quality medical care. We studied 6,992 patients with diabetes in Translating Research Into Action for Diabetes (TRIAD), a prospective observational study of diabetes care in managed care. Foot complications were assessed using administrative claims data. The National Death Index was searched for deaths over 10 years of followup (2000–2009). Charcot neuroosteoarthropathy (CN) and diabetic foot ulcer with debridement (DFU) were associated with an increased risk of mortality; however, the associations were not significant in fully adjusted models. Lower extremity amputation (LEA) was associated with an increased risk of mortality in both unadjusted (HR 3.21, 95% CI 2.50–4.12) and fully adjusted models (HR 1.84, 95% CI 1.28–2.63). When we examined the associations between LEA and mortality stratified by sex and race, risk was increased in men (HR 1.96, 95% CI 1.25–3.07), Hispanics (HR 5.17, 95% CI 1.48–18.01), and Whites (HR 2.18, 95% CI 1.37–3.47). In sensitivity analyses, minor LEA tended to increase the risk of mortality (HR 1.48, 95% CI 0.92–2.40) and major LEA was associated with a significantly higher risk of death at 10 years (HR 1.89, 95% CI 1.18–3.01). In this managed care population with access to high-quality medical care, LEA remained a robust independent predictor of mortality. The association was strongest in men and differed by race.
DOI: 10.2105/ajph.82.8.1145
发表时间: 1992-08-01
影响因子: 12.7
作者:
WILLIAMS, BC;DEMITRACK, LB;FRIES, BE
通讯作者: FRIES, BE
DOI: 10.2337/dc12-0200
发表时间: 2012-10
期刊: Diabetes care
影响因子: 16.2
作者:
Morbach S;Furchert H;Gröblinghoff U;Hoffmeier H;Kersten K;Klauke GT;Klemp U;Roden T;Icks A;Haastert B;Rümenapf G;Abbas ZG;Bharara M;Armstrong DG
通讯作者: Armstrong DG
DOI: 10.1016/0168-8227(91)90034-b
发表时间: 1991-01-01
影响因子: 5.1
作者:
KUMAR, S;FERNANDO, DJS;BOULTON, AJM
通讯作者: BOULTON, AJM
DOI: 10.2337/diacare.24.1.78
发表时间: 2001-01-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Faglia, E;Favales, F;Morabito, A
通讯作者: Morabito, A
DOI: 10.2337/dc08-1695
发表时间: 2009-05
期刊: Diabetes care
影响因子: 16.2
作者:
Sohn MW;Lee TA;Stuck RM;Frykberg RG;Budiman-Mak E
通讯作者: Budiman-Mak E